Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. (ANIK) has a 22-report earnings history dating back to May 06, 2021. Its average absolute post-earnings move is ±9.79%, and 40.9% of those reactions were positive. Its largest post-earnings gain was +16.91% (Feb 26, 2026) and its largest decline was -30.67% (Oct 31, 2024). The next earnings report is predicted for 2026-10-21 (approximate).
Earnings reactions
How ANIK moved on each past earnings report.
Earnings Impact
Total Earnings
22
Avg Abs. Movement
±9.79%
Positive %
40.9%
Negative %
59.1%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Jul 29, 2026 | ☀ PRE | +5.82% | open_in_new |
| Apr 29, 2026 | ☀ PRE | -18.81% | open_in_new |
| Feb 26, 2026 | ☀ PRE | +16.91% | open_in_new |
| Nov 05, 2025 | ☀ PRE | +2.28% | open_in_new |
Earnings Count
22
Total earnings in dataset
Avg Abs. Movement
±9.79%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 144 | 20260807 | open_in_new SEC.gov |
| 4 | 20260805 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260731 | open_in_new SEC.gov |
| 10-Q | 20260729 | open_in_new SEC.gov |
| 8-K | 20260729 | open_in_new SEC.gov |
| S-8 | 20260729 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260717 | open_in_new SEC.gov |
| 8-K | 20260714 | open_in_new SEC.gov |
| 4 | 20260623 | open_in_new SEC.gov |
| 4 | 20260623 | open_in_new SEC.gov |
Frequently asked about ANIK earnings
When does Anika Therapeutics, Inc. report earnings next? expand_more
Anika Therapeutics, Inc. (ANIK)'s next earnings date is approximate for 2026-10-21. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ANIK stock move after earnings? expand_more
Over 22 reports, ANIK has moved an average of ±9.79% the session after earnings, closing higher 40.9% of the time.
What was ANIK's biggest post-earnings move? expand_more
ANIK's largest post-earnings gain on record was +16.91% on Feb 26, 2026, and its largest decline was -30.67% on Oct 31, 2024.
Where can I find Anika Therapeutics, Inc.'s SEC filings? expand_more
All of Anika Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right